Bernstein analyst Lee Hambright upgrades $Edwards Lifesciences (EW.US)$ to a hold rating.
According to TipRanks data, the analyst has a success rate of 70.0% and a total average return of 11.9% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Edwards Lifesciences (EW.US)$'s main analysts recently are as follows:
Edwards Lifesciences experienced a strong performance in terms of sales and earnings, and the forward-looking guidance for Q4, along with future projections up to 2025, are anticipated to sustain the stock's upward trajectory.
The expectation is that it will require several more quarters for Edwards Lifesciences to demonstrate to investors that the lowest point has been reached for its TAVR franchise following the Q3 report.
Expectations were moderate prior to the quarterly results, and the commentary for the third quarter, fourth quarter, and future fiscal year did not strongly suggest that risks had been fully accounted for. Although the deceleration in fourth quarter Transcatheter Aortic Valve Replacement (TAVR) trends may be due to some one-time factors, it remains challenging to counter the possibility that TAVR growth may continue to slow down in the coming fiscal year.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
